Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system.

Area of Science:

• Urology
• Robotic Surgery
• Surgical Technology

Background:

• Robot-Assisted Simple Prostatectomy (RASP) is a key treatment for benign prostatic obstruction (BPO).
• Comparative studies on different robotic platforms for RASP are limited.
• This study addresses the need for comparative data on RASP platforms.

Purpose of the Study:

• To compare perioperative and functional outcomes of RASP performed with the HUGO™ RAS System versus the DaVinci® Xi System.
• To evaluate the efficacy and safety of the HUGO™ RAS System in RASP procedures.
• To provide data supporting the use of alternative robotic platforms in treating BPO.

Main Methods:

• Retrospective study of 40 consecutive RASP cases (May 2021-March 2023).
• Comparison between HUGO™ RAS System and DaVinci® Xi System groups (20 patients each).
• Analysis of baseline characteristics, peri-operative, and functional outcomes by experienced surgeons.

Main Results:

• No significant differences in total operative time, console time, or technical robotic problems between the systems.
• No conversions to open surgery or additional port placements were required.
• Perioperative and functional outcomes were comparable between the HUGO™ RAS and DaVinci® Xi groups (p ≥ 0.2).

Conclusions:

• The HUGO™ RAS System demonstrates comparable perioperative and functional outcomes to the DaVinci® Xi System for RASP.
• Findings support the HUGO™ RAS System as a promising alternative for robot-assisted procedures.
• This expands the potential utilization of robotics for benign urological conditions.